v3.25.1
Discontinued Operations - Details of statements of operations from discontinued operations (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Net revenues $ 7,323 $ 7,462 $ 23,181 $ 24,527
Costs and Expenses:        
Salaries, wages and benefits 2,275 2,652 8,066 7,937
Supplies 30 36 104 109
Rent and lease expense 92 92 279 275
Depreciation and amortization 319 342 956 960
Operating Profit (Loss) (683) (853) (2,889) (1,736)
Other Income (Expense):        
Interest income, net 67 19 167 70
Loss from Continuing Operations before income taxes (630) (834) (2,142) (1,664)
Income Tax Expense 0 (10) 0 (5)
Loss from Discontinued Operations, net of tax (41) (572) (421) (4,156)
Life Sciences And Engineering Segment [Member]        
Net revenues 0 1,886 (46) 7,329
Costs and Expenses:        
Salaries, wages and benefits 5 917 120 4,659
Supplies 0 146 0 702
Purchased services 16 280 85 1,587
Other operating expense 20 452 16 1,509
Rent and lease expense 0 8 0 75
Depreciation and amortization 0 42 0 308
Operating Profit (Loss) (41) 41 (267) (1,511)
Other Income (Expense):        
Impairment loss of Trace Hospital Real Estate and related sale expenses 0 0 (44) (2,032)
Gain (Loss) on Disposition of Other Financial Assets 0 (613) (110) (613)
Loss from Discontinued Operations before income taxes (41) (572) (421) (4,156)
Income Tax Expense 0 0 0 0
Loss from Discontinued Operations, net of tax $ (41) $ (572) $ (421) $ (4,156)